(Reuters) - The frontrunners in the COVID-19 vaccine race have emerged with different success rates for their shots in clinical trials, but what does that mean for the global fight against the pandemic?
U.S. drugmakers Pfizer-BioNtech and Moderna have each said their coronavirus vaccines have an efficacy rate of around 95% and a Russian project touted 92% efficacy for its Sputnik V vaccine.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!